Follow us
Δευ – Παρ : 07:00 π.μ – 05:00 μ.μ


Establishment of Pharmacell by veterinarian Kostas Giannakopoulos, with a focus on the trading of veterinary pharmaceuticals. The initial establishment was a 60 m2 store.


Relocation to a new 200 m2 wholesale and retail store for veterinary pharmaceuticals.


Relocation to a new 1,500 m2 facility in a warehouse and office building to accommodate its growing needs.


The company is transformed into a public limited company and now employs 16 employees. It serves 1,200 clients throughout Greece, including veterinary clinics, livestock units of all species, animal feed industries, and pet shops.


Commencement of production of premixes for all livestock animals. Pharmacell establishes a production line for animal feed supplements in a small initially rented space of 800 m2, located opposite its facilities.

Participation in the research program “AMNOSELECT” in collaboration with the University of Ioannina, the International University of Greece (Department of Animal Production), and the University of Thessaly (Department of Veterinary Medicine). The program focuses on the “Development and implementation of modern methods of gender preselection in sheep, aiming to preserve and increase the genetic capital and productivity of indigenous high-value breeds.”

Participation in the research program “MASTIN,” implemented under the auspices of the General Secretariat for Research and Technology, in collaboration with the Veterinary School and the Department of Chemistry at the Aristotle University of Thessaloniki. The program aims to produce an intramammary formulation without the use of antibiotics for distribution in Greece and internationally.


Pharmacell S.A. relocates to a 4,600 m2 facility in Kalochori, Thessaloniki, which includes a storage and distribution center (logistics), the pharmaceutical retail stores, and the production line for animal feed supplements.



Completion of investments totaling EUR 1.2 million in the premix production facility. This is the most modern and precise unit for producing animal feed supplements in Northern Greece, as well as one of the largest nationwide.

Acquisition of Certification from the top internationally accredited quality and safety system, FAMI-QS. FAMI-QS ensures the hygiene, safety, and quality of the supplements and premixes produced by Pharmacell.

Commencement of its export activities. Pharmacell exports its own manufactured products to the following countries:

  • Poland
  • Latvia
  • Lithuania
  • Cyprus
  • Saudi Arabia


Pharmacell acquires a privately owned facility spanning 10.8 acres, consisting of buildings of 3,500 m2.

The company records a 29% increase in sales compared to 2021, nearing a turnover of €8 million EUR.


Acquires in 2023 the facility in which it is located on 11.2 acres, 4,600 m2.

It employs 35 permanent staff.

It aims to achieve a turnover of EUR 11 million in 2024.